1220.6000 -49.70 (-3.91%)
NSE Aug 01, 2025 15:31 PM
Volume: 2.5M
 

1220.60
-3.91%
BOB Capital Markets Ltd.
Q1 reported 18% EBITDA miss impacted by one-offs in gross margins (PSAI & inventory write-offs in US totaling US$20mn, in my view), while adj. EBITDA was in line.
Deven Choksey released a Sell report for Dr. Reddy's Laboratories Ltd. with a price target of 1120.0 on 29 Jul, 2025.
More from Dr. Reddy's Laboratories Ltd.
Recommended